Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000156 · ClinicalTrials.gov registry record · Phase 3

The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)

A Phase 3 study of Retinopathy of Prematurity, sponsored by National Eye Institute (NEI).

Completed
Registry status
Phase 3
Development phase
3
Study locations

NCT00000156 is a Phase 3 study of Retinopathy of Prematurity that has completed, run by National Eye Institute (NEI). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000156, a Phase 3 study of Retinopathy of Prematurity, has completed, sponsored by National Eye Institute (NEI).

COMPLETED
Registry status
Phase 3
Development phase
3
Study locations

Study Summary

To evaluate the effect of ambient light reduction on the incidence of retinopathy of prematurity (ROP).

Conditions Studied

Retinopathy of Prematurity

Interventions

  • DEVICE Goggles
  • PROCEDURE Ambient Light Reduction

Study Locations (3)

Texas

  • The University of Texas, Southwestern Medical Center at Dallas - Dallas
  • University of Texas, Health Science Center, San Antonio - San Antonio

New York

  • The Children's Hospital of Buffalo - Buffalo

Trial Details

FieldValue
Start Date 1995-07
Phase Phase 3

Sponsor

National Eye Institute (NEI)

221 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00000156

The ClinicalTrials.gov registry entry for NCT00000156 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Retinopathy of Prematurity appearing as the primary indexed condition, and to 2 interventions - of which Goggles is the first listed.

NCT00000156 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Texas, New York.

Frequently Asked Questions

What is clinical trial NCT00000156 about?

NCT00000156 is a clinical study titled "The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)". To evaluate the effect of ambient light reduction on the incidence of retinopathy of prematurity (ROP).

What is the current status of trial NCT00000156?

This trial is currently completed. It is a Phase 3 study. The study started on 1995-07.

What conditions does trial NCT00000156 study?

This clinical trial studies the following conditions: Retinopathy of Prematurity.

What interventions are being tested in trial NCT00000156?

The interventions under investigation include: Goggles (DEVICE), Ambient Light Reduction (PROCEDURE).

Who is sponsoring clinical trial NCT00000156?

This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00000156 being conducted?

This trial has 3 study locations across New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Retinopathy of Prematurity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Retinopathy of Prematurity

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.